769 related articles for article (PubMed ID: 18405445)
1. Radiofrequency ablation for T1a tumors in a solitary kidney: promising intermediate oncologic and renal function outcomes.
Raman JD; Thomas J; Lucas SM; Bensalah K; Lotan Y; Trimmer C; Cadeddu JA
Can J Urol; 2008 Apr; 15(2):3980-5. PubMed ID: 18405445
[TBL] [Abstract][Full Text] [Related]
2. Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques.
Raman JD; Raj GV; Lucas SM; Williams SK; Lauer EM; Ahrar K; Matin SF; Leveillee RJ; Cadeddu JA
BJU Int; 2010 Feb; 105(4):496-500. PubMed ID: 19681900
[TBL] [Abstract][Full Text] [Related]
3. Radiofrequency ablation of renal tumors in the solitary kidney.
Krambeck AE; Farrell MA; Callstrom MR; Atwell TD; Charboneau JW; Chow GK; Dimarco DS; Patterson DE
Can J Urol; 2008 Aug; 15(4):4163-8; discussion 4168. PubMed ID: 18706143
[TBL] [Abstract][Full Text] [Related]
4. Is radiofrequency ablation safe for solitary kidneys?
Jacobsohn KM; Ahrar K; Wood CG; Matin SF
Urology; 2007 May; 69(5):819-23; discussion 823. PubMed ID: 17482911
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation of small renal cortical tumours in healthy adults: renal function preservation and intermediate oncological outcome.
Stern JM; Gupta A; Raman JD; Cost N; Lucas S; Lotan Y; Raj GV; Cadeddu JA
BJU Int; 2009 Sep; 104(6):786-9. PubMed ID: 19426196
[TBL] [Abstract][Full Text] [Related]
6. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years.
Tracy CR; Raman JD; Donnally C; Trimmer CK; Cadeddu JA
Cancer; 2010 Jul; 116(13):3135-42. PubMed ID: 20564644
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with solitary kidney: 6 years experience.
Mylona S; Kokkinaki A; Pomoni M; Galani P; Ntai S; Thanos L
Eur J Radiol; 2009 Feb; 69(2):351-6. PubMed ID: 18313248
[TBL] [Abstract][Full Text] [Related]
8. Functional and oncological outcomes of partial nephrectomy of solitary kidneys.
La Rochelle J; Shuch B; Riggs S; Liang LJ; Saadat A; Kabbinavar F; Pantuck A; Belldegrun A
J Urol; 2009 May; 181(5):2037-42; discussion 2043. PubMed ID: 19298974
[TBL] [Abstract][Full Text] [Related]
9. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours.
Stern JM; Svatek R; Park S; Hermann M; Lotan Y; Sagalowsky AI; Cadeddu JA
BJU Int; 2007 Aug; 100(2):287-90. PubMed ID: 17617136
[TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
[TBL] [Abstract][Full Text] [Related]
11. Short-term efficacy of temperature-based radiofrequency ablation of small renal tumors.
Matsumoto ED; Johnson DB; Ogan K; Trimmer C; Sagalowsky A; Margulis V; Cadeddu JA
Urology; 2005 May; 65(5):877-81. PubMed ID: 15882715
[TBL] [Abstract][Full Text] [Related]
12. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation of renal tumors with an expandable multitined electrode: results, complications, and pilot evaluation of cooled pyeloperfusion for collecting system protection.
Rouvière O; Badet L; Murat FJ; Maréchal JM; Colombel M; Martin X; Lyonnet D; Gelet A
Cardiovasc Intervent Radiol; 2008; 31(3):595-603. PubMed ID: 18247086
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C
Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous radiofrequency ablation of renal tumors in solitary kidney patients.
Jiménez E; Zurera L; Espejo JJ; Requena MJ; Campos P; Rodríguez de Tembleque L; Canis M
Arch Esp Urol; 2011; 64(1):51-8. PubMed ID: 21289386
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y
Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597
[TBL] [Abstract][Full Text] [Related]
17. Nephron-sparing surgery for renal cell carcinoma in the solitary kidney.
Berdjis N; Hakenberg OW; Novotny V; Manseck A; Oehlschläger S; Wirth MP
Scand J Urol Nephrol; 2007; 41(1):10-3. PubMed ID: 17366096
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation in combination with embolization in metachronous recurrent renal cancer in solitary kidney after contralateral tumor nephrectomy.
Gebauer B; Werk M; Lopez-Hänninen E; Felix R; Althaus P
Cardiovasc Intervent Radiol; 2007; 30(4):644-9. PubMed ID: 17436034
[TBL] [Abstract][Full Text] [Related]
19. No evidence of disease after radiofrequency ablation in delayed nephrectomy specimens.
Park S; Strup SE; Saboorian H; Cadeddu JA
Urology; 2006 Nov; 68(5):964-7. PubMed ID: 17113888
[TBL] [Abstract][Full Text] [Related]
20. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass.
Levinson AW; Su LM; Agarwal D; Sroka M; Jarrett TW; Kavoussi LR; Solomon SB
J Urol; 2008 Aug; 180(2):499-504; discussion 504. PubMed ID: 18550123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]